Amy Rachel Moore (A Rachel Moore)

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvie D Freeman, Abin Thomas, Ian Thomas, Robert K Hills, Paresh Vyas, Amanda Frances Gilkes, Marlen Metzner, Niels Asger Jakobsen, Alison Kennedy, Amy Rachel Moore, Nuria Marquez-Almuina, Sarah Burns, Sophie King, Georgia Andrew, Kathleen M E Gallagher, Rob S Sellar, Paul A Cahalin, Duruta Weber, Mike Dennis, Priyanka Mehta, Stephen Knapper, Nigel H Russell
Fractionated Versus Single Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older AML: UK NCRI AML18 Trial. Blood (2023)
Amy Rachel Moore, Jing Yu, Yang Pei, Emily W Y Cheng, Ana Lisa Taylor Tavares, Woolf T Walker, N Simon Thomas, Arveen Kamath, Rita Ibitoye, Dragana Josifova, Anna Wilsdon, Alison Ross, Alistair D Calder, Amaka C Offiah, Andrew O M Wilkie, null null, Jenny C Taylor, Alistair T Pagnamenta
Use of genome sequencing to hunt for cryptic second-hit variants: analysis of 31 cases recruited to the 100 000 Genomes Project. Journal of medical genetics (2023)

Amy Rachel Moore.css-eqlu8i{font-size:small;padding-left:4px;} (A Rachel Moore)